We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+2.99%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$4.36B
AUM Growth
+$1.42B
Cap. Flow
+$2.09B
Cap. Flow %
47.88%
Top 10 Hldgs %
44.57%
Holding
147
New
40
Increased
52
Reduced
12
Closed
36

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$86.1M
2
TJX icon
TJX Companies
TJX
+$75.5M
3
TVTX icon
Travere Therapeutics
TVTX
+$65.1M
4
AMZN icon
Amazon
AMZN
+$63.1M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$52.3M

Top Sells

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$45.4M
2
ORLY icon
O'Reilly Automotive
ORLY
+$41M
3
ULTA icon
Ulta Beauty
ULTA
+$39.7M
4
FIVE icon
Five Below
FIVE
+$38M
5
FTDR icon
Frontdoor
FTDR
+$32.9M

Sector Composition

Rank Sector Weight
1 Healthcare 46.59%
2 Consumer Staples 10.1%
3 Consumer Discretionary 9.65%
4 Technology 2.31%
5 Industrials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENR icon
26
Energizer
ENR
$1.44B
$49.7M 1.14%
1,048,000
+70,000
+7% +$3.22M
KO icon
27
Coca-Cola
KO
$377B
$48.3M 1.11%
916,000
+316,000
+53% +$15.9M
CLX icon
28
Clorox
CLX
$11.6B
$48.2M 1.11%
250,000
+190,000
+317% +$36.6M
CPB icon
29
Campbell Soup
CPB
$6.55B
$46.4M 1.07%
924,000
+156,000
+20% +$7.43M
CPRX
30
DELISTED
Catalyst Pharmaceutical
CPRX
$46.1M 1.06%
10,000,000
– –
BUD icon
31
AB InBev
BUD
$170B
$44M 1.01%
+700,000
New +$45.2M
PFE icon
32
Pfizer
PFE
$143B
$43.5M 1%
+1,200,000
New +$42.6M
NKE icon
33
Nike
NKE
$61.9B
$42.9M 0.98%
+322,491
New +$44.8M
OCDX
34
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$42.4M 0.97%
+2,196,000
New +$38.7M
ARGX icon
35
argenx
ARGX
$53.4B
$41.3M 0.95%
150,000
+70,000
+88% +$22.1M
CENTA icon
36
Central Garden & Pet Co Class A
CENTA
$2.37B
$41.1M 0.94%
990,000
-340,000
-26% -$11.6M
MDGL icon
37
Madrigal Pharmaceuticals
MDGL
$10.8B
$40.9M 0.94%
350,000
+34,000
+11% +$3.96M
RL icon
38
Ralph Lauren
RL
$22.6B
$35.8M 0.82%
+290,517
New +$33.1M
BABA icon
39
Alibaba
BABA
$293B
$34.9M 0.8%
154,000
+50,000
+48% +$12.3M
SPPI
40
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$34.9M 0.8%
10,700,000
+1,108,000
+12% +$3.97M
MDLZ icon
41
Mondelez International
MDLZ
$79.5B
$31.4M 0.72%
536,000
+144,000
+37% +$8.13M
BNTX icon
42
BioNTech
BNTX
$22.9B
$30.1M 0.69%
276,000
+40,000
+17% +$4.25M
DXCM icon
43
DexCom
DXCM
$31.5B
$29.5M 0.68%
328,000
+72,000
+28% +$6.76M
PARA
44
DELISTED
Paramount Global Class B
PARA
$28.1M 0.65%
+624,000
New +$38.1M
TMO icon
45
Thermo Fisher Scientific
TMO
$213B
$26.5M 0.61%
58,000
+19,000
+49% +$9.07M
NUVA
46
DELISTED
NuVasive, Inc.
NUVA
$26.2M 0.6%
400,000
-140,000
-26% -$8.4M
ADBE icon
47
Adobe
ADBE
$99.5B
$25.7M 0.59%
54,000
+42,000
+350% +$19.6M
MSFT icon
48
Microsoft
MSFT
$3.45T
$25.5M 0.58%
108,000
+50,000
+86% +$11.6M
NTRA icon
49
Natera
NTRA
$38.3B
$25.2M 0.58%
248,000
+132,000
+114% +$14.5M
AXNX
50
DELISTED
Axonics, Inc. Common Stock
AXNX
$25M 0.57%
418,000
+170,000
+69% +$9.24M
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Armistice Capital held 147 positions worth $4.36B, up 48% from $2.94B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Armistice Capital deployed $2.09B of net new capital in Q1 2021, opening 40 new positions and adding to 52 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 392,000 shares worth $84.2M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Lantheus, an estimated $45.4M trimmed.

  • Armistice Capital's largest Q1 2021 buy was Vertex Pharmaceuticals: 392,000 shares worth $84.2M.
  • Armistice Capital added most to Amazon in Q1 2021, an estimated $63.1M increase.
  • Armistice Capital's biggest Q1 2021 reduction was Lantheus, cutting an estimated $45.4M.
  • Armistice Capital fully exited O'Reilly Automotive in Q1 2021, selling an estimated $41M.
  • Armistice Capital's ten largest holdings make up 45% of its $4.36B portfolio in Q1 2021.
  • Armistice Capital opened 40 new positions and closed 36 in Q1 2021.
  • Armistice Capital's portfolio value rose 48% quarter-over-quarter to $4.36B.

Based on Armistice Capital's 13F filing for Q1 2021, filed 17 May 2021.